Trial Profile
A Phase 1/2 Study Evaluating the Safety, Tolerability and Efficacy of KP-413 Topical Ointment in Subjects With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs KP 413 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Kaken Pharmaceutical
- 02 May 2014 New trial record